What is the Historic and Current Scenario of the Intraoperative Neuromonitoring Market?
The intraoperative neuromonitoring market has seen considerable growth due to a variety of factors.
• In recent times, there has been substantial growth in the size of the intraoperative neuromonitoring market. The market, which was valued at $3.56 billion in 2024, is set to increase to $3.8 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. The notable growth during the historic period can be credited to factors such as a surge in neurological disorders, an increased awareness amongst surgeons, the broadened applications in several types of surgeries, a rise in the elderly population, and favorable insurance and reimbursement policies.
What Is The Expected Growth In The Intraoperative Neuromonitoring Template Market?
The Intraoperative Neuromonitoring market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for intraoperative neuromonitoring is projected to experience significant expansion in the upcoming years. With a compound annual growth rate (CAGR) of 8.3%.
, it is estimated to escalate to $5.23 billion by 2029. Factors contributing to growth during the forecast period include a rise in demand for minimally invasive surgeries, a global increase in surgical procedures, heightened concern for patient safety, extension into new areas of medicine, and government policies and initiatives. Key trends for the forecasted period include advances in technology, devices integrated with the Internet of Things (IoT), innovation in products, and strategic partnerships.
What Main Forces Are Fueling Expansion In The Intraoperative Neuromonitoring Market?
Growing incidences of neurovascular conditions are anticipated to stimulate the expansion of the intraoperative neuromonitoring market. Neurovascular conditions include prolonged illnesses like Parkinson's disease, Alzheimer's disease, and epilepsy. Intraoperative neuromonitoring is utilized to examine the health of neural structures and awareness during surgery for various neurological ailments, including Alzheimer's disease. For example, the US-based federal agency, National Library Of Medicine, estimates that around 6.2 million Americans aged 65 and over are affected by Alzheimer's dementia, a number projected to rise to 13.8 million by 2060. Consequently, the rise in neurovascular condition cases fuels the growth of the intraoperative neuromonitoring market.
What Are The Primary Segments In The Global Intraoperative Neuromonitoring Market?
The intraoperative neuromonitoring market covered in this report is segmented –
1) By Products And Services: Systems, Accessories, Services
2) By Modality: Motor Evoked Potentials, Somatosensory Evoked Potentials, Electroencephalography, Electromyography, Brainstem Auditory Evoked Potentials, Visual Evoked Potentials
3) By Application: Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, Other Surgeries
4) By End User: Hospitals, Ambulatory Surgical centers
Subsegments:
1) By Systems: Electromyography (EMG) Systems, Electroencephalography (EEG) Systems, Evoked Potential (EP) Systems, Multimodal Monitoring Systems
2) By Accessories: Electrodes, Cables And Connectors, Amplifiers, Monitors And Display Units
3) By Services: Consulting Services, Technical Support And Maintenance, Training And Education Services, Data Analysis And Reporting Services
Pre-Book The Intraoperative Neuromonitoring Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Intraoperative Neuromonitoring Market?
The growing acceptance of high-tech devices in intraoperative neuromonitoring represents a leading trend in the intraoperative neuromonitoring market. Major firms in this market are concentrating on inventing new technological solutions to solidify their foothold. A case in point being, in October 2023, the medical device manufacturer based in Japan, Nihon Kohden, introduced their One View solution. This cutting-edge attribute is part of the Neuromaster G1 intraoperative neuromonitoring (IONM) system. The solution grants perfect incorporation of the patient's anesthesia and critical signs such as heart rate, SpO2, temperature, among others, with the neurological data contained in the IONM software. It includes a personalizable pop-up notification system equipped with auditory signals to initiate fast actions and immediate interventions. These notifications can be set to activate when they reach pre-set threshold parameters.
Who Are the Key Players In The Intraoperative Neuromonitoring Market?
Major companies operating in the intraoperative neuromonitoring market include:
• Medtronic PLC
• Natus Medical Incorporated
• Cadwell Industries Inc.
• Siemens Healthineers
• Neurosign
• Mizuho Medical Co. Ltd.
• EEG Solutions Inc.
• Invenia Technical Computing
• Cablescope Inc.
• Blackrock Neurotech
• Specialty Surgical Instrumentation
• NeuroWave Systems
• Intraoperative Monitoring Services LLC
• BrainScope Company
• Inc.
• Trident Medical Inc.
• CortiCare
• Soterix Medical
• Viking Medical
• Neuromonitoring Associates
• NeuroVigil
• Neurophysiology Associates
• NeuroDiagnostic Institute
• Biomedical Monitoring Inc.
• The EPI Group
• Advanced Neuromonitoring Technologies
• Amplified NeuroTech
What Is The Most Dominant Region In The Intraoperative Neuromonitoring Market?
North America was the largest region in the intraoperative neuromonitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intraoperative neuromonitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
